Literature DB >> 28474162

[Hereditary colorectal cancer : An update on genetics and entities in terms of differential diagnosis].

T T Rau1, H Dawson2, A Hartmann3, J Rüschoff4.   

Abstract

The pathologist can contribute to recognizing hereditary causes of colorectal cancer via morphology. By identifying so-called index patients, it is possible to take preventive measures in affected families. The precise definition of the clinical presentation and the histopathological phenotype help to narrow the spectrum of expected genetic alterations. Novelties within Lynch syndrome include the recognition of EPCAM as a fifth gene locus, as well as the newly defined Lynch-like syndrome with evidence of somatic mismatch repair (MMR) mutations. With regard to polyposis-associated syndromes, the spectrum of polyps, whether serrated, hamartomatous or classic adenoma, is of crucial importance. The resulting differential diagnosis includes (attenuated) familial adenomatous polyposis ([a]FAP), MUTYH-associated polyposis (MAP), polymerase proofreading-associated polyposis (PPAP), phosphatase and tensin homolog (PTEN) hamartoma tumor syndrome (PHTS), Peutz-Jeghers syndrome and juvenile polyposis, each with a specific genetic background.

Entities:  

Keywords:  Juvenile polyposis; Lynch syndrome; Peutz-Jeghers syndrome; Phosphatase and tensin homolog (PTEN) hamartoma tumor syndrome (PHTS); Polymerase proofreading-associated polyposis (PPAP)

Mesh:

Year:  2017        PMID: 28474162     DOI: 10.1007/s00292-017-0294-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  27 in total

1.  Recurrence and variability of germline EPCAM deletions in Lynch syndrome.

Authors:  Roland P Kuiper; Lisenka E L M Vissers; Ramprasath Venkatachalam; Danielle Bodmer; Eveline Hoenselaar; Monique Goossens; Aline Haufe; Eveline Kamping; Renée C Niessen; Frans B L Hogervorst; Johan J P Gille; Bert Redeker; Carli M J Tops; Marielle E van Gijn; Ans M W van den Ouweland; Nils Rahner; Verena Steinke; Philip Kahl; Elke Holinski-Feder; Monika Morak; Matthias Kloor; Susanne Stemmler; Beate Betz; Pierre Hutter; David J Bunyan; Sapna Syngal; Julie O Culver; Tracy Graham; Tsun L Chan; Iris D Nagtegaal; J Han J M van Krieken; Hans K Schackert; Nicoline Hoogerbrugge; Ad Geurts van Kessel; Marjolijn J L Ligtenberg
Journal:  Hum Mutat       Date:  2011-03-01       Impact factor: 4.878

2.  Frequency and spectrum of cancers in the Peutz-Jeghers syndrome.

Authors:  Nicholas Hearle; Valérie Schumacher; Fred H Menko; Sylviane Olschwang; Lisa A Boardman; Johan J P Gille; Josbert J Keller; Anne Marie Westerman; Rodney J Scott; Wendy Lim; Jill D Trimbath; Francis M Giardiello; Stephen B Gruber; G Johan A Offerhaus; Felix W M de Rooij; J H Paul Wilson; Anika Hansmann; Gabriela Möslein; Brigitte Royer-Pokora; Tilman Vogel; Robin K S Phillips; Allan D Spigelman; Richard S Houlston
Journal:  Clin Cancer Res       Date:  2006-05-15       Impact factor: 12.531

3.  Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.

Authors:  Brandie Heald; Jessica Mester; Lisa Rybicki; Mohammed S Orloff; Carol A Burke; Charis Eng
Journal:  Gastroenterology       Date:  2010-06-27       Impact factor: 22.682

4.  Defining the adenoma burden in lynch syndrome.

Authors:  Matthew F Kalady; Sara E Kravochuck; Brandie Heald; Carol A Burke; James M Church
Journal:  Dis Colon Rectum       Date:  2015-04       Impact factor: 4.585

5.  Peutz-Jeghers syndrome: a critical look at colonic Peutz-Jeghers polyps.

Authors:  Julie Y Tse; Shulin Wu; Shweta A Shinagare; Gregory Y Lauwers; Omer Yilmaz; Chin-Lee Wu; Vikram Deshpande
Journal:  Mod Pathol       Date:  2013-04-19       Impact factor: 7.842

6.  Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps.

Authors:  Carla Guarinos; Miriam Juárez; Cecilia Egoavil; María Rodríguez-Soler; Lucía Pérez-Carbonell; Ramón Salas; Joaquín Cubiella; Francisco Rodríguez-Moranta; Luisa de-Castro; Luis Bujanda; Anna Serradesanferm; David Nicolás-Pérez; Maite Herráiz; Fernando Fernández-Bañares; Alberto Herreros-de-Tejada; Elena Aguirre; Judith Balmaña; María-Luisa Rincón; Angeles Pizarro; Francisco Polo-Ortiz; Adela Castillejo; Cristina Alenda; Artemio Payá; José-Luis Soto; Rodrigo Jover
Journal:  Clin Cancer Res       Date:  2014-01-27       Impact factor: 12.531

Review 7.  Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.

Authors:  Robert Pilarski; Randall Burt; Wendy Kohlman; Lana Pho; Kristen M Shannon; Elizabeth Swisher
Journal:  J Natl Cancer Inst       Date:  2013-10-17       Impact factor: 13.506

Review 8.  Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis.

Authors:  Laura Valle
Journal:  Clin Gastroenterol Hepatol       Date:  2016-10-03       Impact factor: 11.382

9.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

Review 10.  POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance.

Authors:  Fernando Bellido; Marta Pineda; Gemma Aiza; Rafael Valdés-Mas; Matilde Navarro; Diana A Puente; Tirso Pons; Sara González; Silvia Iglesias; Esther Darder; Virginia Piñol; José Luís Soto; Alfonso Valencia; Ignacio Blanco; Miguel Urioste; Joan Brunet; Conxi Lázaro; Gabriel Capellá; Xose S Puente; Laura Valle
Journal:  Genet Med       Date:  2015-07-02       Impact factor: 8.822

View more
  3 in total

Review 1.  Hematological Malignancies in Adults With a Family Predisposition.

Authors:  Tilmann Bochtler; Georg-Martin Haag; Sarah Schott; Matthias Kloor; Alwin Krämer; Carsten Müller-Tidow
Journal:  Dtsch Arztebl Int       Date:  2018-12-14       Impact factor: 5.594

Review 2.  [BRAF-V600E testing in metastatic colorectal cancer and new, chemotherapy-free therapy options. German version].

Authors:  Michael Hummel; Susanna Hegewisch-Becker; Jens Neumann; Arndt Vogel
Journal:  Pathologe       Date:  2021-05-06       Impact factor: 1.011

Review 3.  BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options.

Authors:  Michael Hummel; Susanna Hegewisch-Becker; Jens H L Neumann; Arndt Vogel
Journal:  Pathologe       Date:  2021-07-14       Impact factor: 1.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.